key: cord-0771351-652kmcb1 authors: Vaught, Eric S; Rogers, Greg A; Ryan, Keith E; Averitt, Andrew W; Rice, Jeffrey M title: Prolonged Sars-CoV-2 Viral Culture Detected in a Mild COVID-19 Infection date: 2021-04-09 journal: Mil Med DOI: 10.1093/milmed/usab136 sha: 8a1eededfa6fd687dfedaa2650dcdeea7b246445 doc_id: 771351 cord_uid: 652kmcb1 We describe a case of prolonged shedding of live Severe Acute Respiratory Syndrome Coronavirus, 2 in the setting of a mild novel Coronavirus Disease 2019 (COVID-19) infection in a healthy young adult male. The patient did not require hospitalization or any supplemental oxygen. The viral cultures remained positive 15 days from symptom onset. The extended duration of positive viral culture with his concurrent mild symptomatology is at odds with current CDC and DOD isolation policies for positive COVID-19 patients. This case is important as health agencies around the world grapple with how to advise patients and create protocols for isolation precautions after positive COVID-19 results. The Severe Acute Respiratory Syndrome Coronavirus, 2 (SARS-CoV-2) causes the novel Coronavirus Disease 2019 . Current diagnostic testing includes a nasopharyngeal or anterior nares swab and polymerase chain reaction (PCR) technology to look for nucleotide evidence of COVID-19 infection. However, this diagnostic test does not provide information on infectivity or viral shedding as the presence of nucleotide remnants can remain long after the disappearance of infectious virus. 1 Viral culture provides more information regarding viral infectivity and activity; however, it is not commonly used in clinical practice because of its low sensitivity and long turn-around time for virus detection. 2 Our case is one example of a COVID-19 patient with minimal symptoms with prolonged shedding of culture viable virus. Our patient is a 31 year-old Asian/White American male active duty aircraft pilot. He has no past medical or surgical history, takes no medications, has no known allergies, and is a non-smoker. His initial symptoms were myalgias, headache, and a sporadic dry cough. He took a home oral temperature of 101 • F. He denied any nausea, vomiting, abdominal pain, diarrhea, rash, and sore throat. He disclosed a recent travel history for a small family wedding 1 week before symptom onset but denied any symptomatic close contacts or contacts that later developed symptoms. The wedding occurred in March 2020, was mixed indoor and outdoor, and no individuals were wearing masks. The patient states he practiced what he considers standard hand hygiene, including washing his hands after using the restroom and before meals. He presented to the clinic for examination 1 day from symptom onset. He was noted to have a frequent, dry cough without dyspnea, a temperature of 98.7 • F via forehead scan temperature, and an oxygen saturation of >98%. He reported 325 mg acetaminophen 3 hours before clinic visit. He was tested with a nasopharyngeal swab for COVID-19 Real-Time Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) and influenza A and B PCR. Our patient's COVID-19 PCR returned positive on day 3 from symptoms, the influenza A and B PCR tests were negative. He was isolated at his home for the duration of his illness, only returning to clinic for further COVID PCR testing. His headache, fever, and myalgias resolved at 48-72 hours after initial onset of symptoms. His dry cough persisted, improving daily, until it completely resolved at day 22 from symptom onset. On day 7 from symptom onset, he lost his sense of taste and smell. He regained his sense of taste and smell 3 weeks from symptom onset. He received no medical interventions, and only used acetaminophen as needed during the first 3 days of illness. At this time, we followed the Navy Medicine policy for releasing patients from quarantine after resolution of the fever and improvement in respiratory symptoms and two negative nasopharyngeal PCR swabs in an interval of more than 24 hours. 3 We chose the lab-based method over the exclusively symptom-based method because we believed it would guarantee that he was not shedding live virus once the PCR test was negative. Our squadron was in the process of preparing for an immediate reaction force deployment, and we did not want to expose the squadron to COVID-19 virus and jeopardize our ability to deploy. As resources permitted, the swabs were sent for viral culture on days 3, 15, and 22 from symptom onset. Our patient's viral culture remained positive through day 15 from symptom onset and was negative on day 22 from symptom onset. In a recent issue of the Lancet Microbe, a large systematic review and meta-analysis was completed characterizing viral load dynamics, duration of viral RNA shedding, and viable virus shedding of SARS-CoV-2 in various body fluids. In their meta-analysis, they concluded that "no study detected live virus (via culture) beyond day 9 of illness, despite persistently high viral loads, which were inferred from cycle threshold values". 4 Our literature review only found two cases with longer duration of viral shedding as seen by positive viral cultures. One case isolated culture viable virus from respiratory specimens collected in a hospitalized 50 year old woman, 18 days after symptom onset. 5 In another case, virus was detected in culture 20 days after onset of symptoms in a patient requiring hospitalization because of severity of symptoms. 6 Our case is unique to these other two case reports as our patient is young and had mild symptoms not requiring hospitalization. The CDC guidelines state, perhaps to aggressively, that "for most persons with COVID-19 illness, isolation and precautions can generally be discontinued 10 days after symptom onset and resolution of fever for at least 24 hours, without the use of fever-reducing medications, and with improvement of other symptoms." They also state that "a limited number of persons with severe illness may produce replicationcompetent virus beyond 10 days that may warrant extending duration of isolation and precautions for up to 20 days after symptom onset; consider consultation with infection control experts". 7 Current DoD and U.S. Navy policy is consistent with the CDC's guidelines. If we had followed the current CDC guidelines for our patient, he would have continued to be infectious and shed live virus for 5 days after release from quarantine. Our case shows that current isolation duration and "Return to Work" guidelines may need to be adjusted, perhaps extending the isolation period. Alternative strategies could be instructing individuals being released from 10 day quarantine to wear an N-95 masks, or layer masks, 8 for an additional 7-10 days. Cases of prolonged viral shedding appear rare in the literature. It is also rare to use viral culture analysis for young healthy individuals with mild symptoms who do not require hospitalization. We cannot confidently say how many individuals with mild symptoms continue to spread virus for greater than 10 days. Our case indicates quarantine policies may need to be adjusted. It also highlights the importance of studying infectivity in patients with both mild and severe symptoms, as well as studying patients of differing demographics including those who are young and without pre-existing medical conditions. Lastly, it demonstrates the importance of wearing masks and social distancing even after a patient has finished quarantining. SARS-CoV-2 shedding and infectivity Practical guidance for clinical microbiology laboratories: viruses causing acute respiratory tract infections Available at SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis Prolonged virus shedding even after seroconversion in a patient with COVID-19 Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants CDC: Discontinuation of transmission-based precautions and disposition of patients with COVID-19 in healthcare settings (interim guidance) CDC: Improve how your mask protects you None declared. None of the authors have financial conflicts of interest to disclose. None of the authors report conflicts of interest.